financetom
Business
financetom
/
Business
/
Bionano Genomics Plans $9 Million Public Offering
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bionano Genomics Plans $9 Million Public Offering
Sep 11, 2025 9:34 AM

12:20 PM EDT, 09/11/2025 (MT Newswires) -- Bionano Genomics ( BNGO ) on Thursday disclosed a combined public offering of shares and accompanying warrants to raise an expected $9 million in proceeds.

The company will issue up to 2 million shares of common stock, together with Series E and Series F warrants, at an assumed combined price of $4.92 per share and accompanying warrants, according to a regulatory filing.

The company said it intends to use net proceeds from the offering for working capital and general corporate purposes.

Bionano said that the offering will terminate on Oct. 11.

Price: 4.88, Change: -0.04, Percent Change: -0.73

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck's Investigational Drug in Treatment-Naive Adults with HIV-1 Infection Shows Primary Efficacy
Merck's Investigational Drug in Treatment-Naive Adults with HIV-1 Infection Shows Primary Efficacy
Nov 19, 2025
07:37 AM EST, 11/19/2025 (MT Newswires) -- Merck ( MRK ) said Wednesday the pivotal phase 3 trial of its investigational regimen of doravirine/islatravir in treatment-naive adults with HIV-1 infection met its success criterion of primary efficacy. Trial topline results showed the non-inferiority of the drug and a comparable safety profile to once-daily oral bictegravir/emtricitabine/tenofovir alafenamide, Merck ( MRK )...
TJX Q3 revenue beats estimates
TJX Q3 revenue beats estimates
Nov 19, 2025
Overview * TJX Q3 FY26 revenue grows 7% yr/yr, beating analyst expectations * Q3 diluted EPS rises 12% to $1.28, exceeding company plan * Company returned $1.1 bln to shareholders via buybacks and dividends in Q3 Outlook * Company expects Q4 comp sales to rise 2% to 3% * TJX raises full-year EPS outlook to $4.63-$4.66 * Company plans $2.5...
TJ Maxx parent TJX raises annual profit forecast
TJ Maxx parent TJX raises annual profit forecast
Nov 19, 2025
(Reuters) -TJX Cos ( TJX ) raised annual profit forecast on Wednesday, anticipating that broad sourcing strategy and seasonal inventory will attract bargain-hunting shoppers to its off-price stores. Shares of the company rose about 3% in premarket trading. They have risen nearly 21% so far this year. The Framingham, Massachusetts-based company has capitalized on a seasonal shift from late-summer to...
Dana, Allison Transmission Receive Regulatory Approvals for Off-Highway Business Deal
Dana, Allison Transmission Receive Regulatory Approvals for Off-Highway Business Deal
Nov 19, 2025
07:38 AM EST, 11/19/2025 (MT Newswires) -- Dana (DAN) and Allison Transmission ( ALSN ) said Wednesday they have received all required regulatory approvals for the previously announced sale of Dana's off-highway business to Allison. The transaction is expected to close at or near the year-end, the companies said. The transaction has enabled Dana to return $600 million to shareholders...
Copyright 2023-2026 - www.financetom.com All Rights Reserved